Real-time enrollment status for this lennox-gastaut syndrome clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:07 PM UTC
| NCT Number | NCT05066217 |
| Recruiting Status | Recruiting |
| Condition | Lennox-Gastaut Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 260 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Epygenix |
| Last Updated on CT.gov | July 2, 2026 (2 weeks ago) |
As of July 17, 2026: Clinical trial NCT05066217 is currently recruiting participants. This phase3 study for lennox-gastaut syndrome is actively seeking new participants at 24 locations across the United States. The study is sponsored by Epygenix. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05066217 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05066217 was last updated 2 weeks ago (July 2, 2026). HelloStudys verifies this status automatically.